Literature DB >> 17392427

Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways.

Barbara Stecca1, Christophe Mas, Virginie Clement, Marie Zbinden, Rafael Correa, Vincent Piguet, Friedrich Beermann, Ariel Ruiz I Altaba.   

Abstract

Melanoma is one of the most aggressive cancers, and its incidence is increasing. These tumors derive from the melanocyte lineage and remain incurable after metastasis. Here we report that SONIC HEDGEHOG (SHH)-GLI signaling is active in the matrix of human hair follicles, and that it is required for the normal proliferation of human melanocytes in culture. SHH-GLI signaling also regulates the proliferation and survival of human melanomas: the growth, recurrence, and metastasis of melanoma xenografts in mice are prevented by local or systemic interference of HH-GLI function. Moreover, we show that oncogenic RAS-induced melanomas in transgenic mice express Gli1 and require Hh-Gli signaling in vitro and in vivo. Finally, we provide evidence that endogenous RAS-MEK and AKT signaling regulate the nuclear localization and transcriptional activity of GLI1 in melanoma and other cancer cells. Our data uncover an unsuspected role of HH-GLI signaling in melanocytes and melanomas, demonstrate a role for this pathway in RAS-induced tumors, suggest a general integration of the RAS/AKT and HH-GLI pathways, and open a therapeutic approach for human melanomas.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17392427      PMCID: PMC1838820          DOI: 10.1073/pnas.0700776104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation.

Authors:  Joon Won Yoon; Yasuhiro Kita; Daniel J Frank; Rebecca R Majewski; Beth A Konicek; Marcelo A Nobrega; Howard Jacob; David Walterhouse; Philip Iannaccone
Journal:  J Biol Chem       Date:  2001-11-21       Impact factor: 5.157

2.  The gene encoding the T-box factor Tbx2 is a target for the microphthalmia-associated transcription factor in melanocytes.

Authors:  S Carreira; B Liu; C R Goding
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

3.  Mammalian suppressor-of-fused modulates nuclear-cytoplasmic shuttling of Gli-1.

Authors:  P Kogerman; T Grimm; L Kogerman; D Krause; A B Undén; B Sandstedt; R Toftgård; P G Zaphiropoulos
Journal:  Nat Cell Biol       Date:  1999-09       Impact factor: 28.824

4.  A role of PDGFRalpha in basal cell carcinoma proliferation.

Authors:  J Xie; M Aszterbaum; X Zhang; J M Bonifas; C Zachary; E Epstein; F McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

5.  The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma.

Authors:  Edgar Selzer; Volker Wacheck; Trevor Lucas; Elisabeth Heere-Ress; Min Wu; Katherine N Weilbaecher; Werner Schlegel; Peter Valent; Fritz Wrba; Hubert Pehamberger; David Fisher; Burkhard Jansen
Journal:  Cancer Res       Date:  2002-04-01       Impact factor: 12.701

6.  Dominant role of the niche in melanocyte stem-cell fate determination.

Authors:  Emi K Nishimura; Siobhán A Jordan; Hideo Oshima; Hisahiro Yoshida; Masatake Osawa; Mariko Moriyama; Ian J Jackson; Yann Barrandon; Yoshiki Miyachi; Shin-Ichi Nishikawa
Journal:  Nature       Date:  2002-04-25       Impact factor: 49.962

7.  A tumorigenic subpopulation with stem cell properties in melanomas.

Authors:  Dong Fang; Thiennga K Nguyen; Kim Leishear; Rena Finko; Angela N Kulp; Susan Hotz; Patricia A Van Belle; Xiaowei Xu; David E Elder; Meenhard Herlyn
Journal:  Cancer Res       Date:  2005-10-15       Impact factor: 12.701

8.  Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability.

Authors:  Gaël G McGill; Martin Horstmann; Hans R Widlund; Jinyan Du; Gabriela Motyckova; Emi K Nishimura; Yi-Ling Lin; Sridhar Ramaswamy; William Avery; Han-Fei Ding; Siobhán A Jordan; Ian J Jackson; Stanley J Korsmeyer; Todd R Golub; David E Fisher
Journal:  Cell       Date:  2002-06-14       Impact factor: 41.582

9.  The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis.

Authors:  N Dahmane; P Sánchez; Y Gitton; V Palma; T Sun; M Beyna; H Weiner; A Ruiz i Altaba
Journal:  Development       Date:  2001-12       Impact factor: 6.868

10.  Gli2 functions in FGF signaling during antero-posterior patterning.

Authors:  R Brewster; J L Mullor; A Ruiz i Altaba
Journal:  Development       Date:  2000-10       Impact factor: 6.868

View more
  231 in total

Review 1.  Targeting Hedgehog--a cancer stem cell pathway.

Authors:  Akil A Merchant; William Matsui
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

2.  DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS.

Authors:  Matthias Lauth; Asa Bergström; Takashi Shimokawa; Ulrica Tostar; Qianren Jin; Volker Fendrich; Carmen Guerra; Mariano Barbacid; Rune Toftgård
Journal:  Nat Struct Mol Biol       Date:  2010-05-30       Impact factor: 15.369

3.  NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53.

Authors:  Marie Zbinden; Arnaud Duquet; Aiala Lorente-Trigos; Sandra-Nadia Ngwabyt; Isabel Borges; Ariel Ruiz i Altaba
Journal:  EMBO J       Date:  2010-06-25       Impact factor: 11.598

Review 4.  Hedgehog signalling in breast cancer.

Authors:  Maria Kasper; Viljar Jaks; Marie Fiaschi; Rune Toftgård
Journal:  Carcinogenesis       Date:  2009-02-23       Impact factor: 4.944

Review 5.  Safety and Tolerability of Sonic Hedgehog Pathway Inhibitors in Cancer.

Authors:  Richard L Carpenter; Haimanti Ray
Journal:  Drug Saf       Date:  2019-02       Impact factor: 5.606

6.  The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma.

Authors:  Verline Justilien; Michael P Walsh; Syed A Ali; E Aubrey Thompson; Nicole R Murray; Alan P Fields
Journal:  Cancer Cell       Date:  2014-02-10       Impact factor: 31.743

Review 7.  The hedgehog pathway in nonalcoholic fatty liver disease.

Authors:  Mariana Verdelho Machado; Anna Mae Diehl
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-03-20       Impact factor: 8.250

8.  The GLI1 splice variant TGLI1 promotes glioblastoma angiogenesis and growth.

Authors:  Hu Zhu; Richard L Carpenter; Woody Han; Hui-Wen Lo
Journal:  Cancer Lett       Date:  2013-09-15       Impact factor: 8.679

Review 9.  Cancer stem cells in lung cancer: Evidence and controversies.

Authors:  Muhammad Alamgeer; Craig D Peacock; William Matsui; Vinod Ganju; D Neil Watkins
Journal:  Respirology       Date:  2013-07       Impact factor: 6.424

10.  Gli1 promotes cell survival and is predictive of a poor outcome in ERalpha-negative breast cancer.

Authors:  Lusheng Xu; Yeon-Jin Kwon; Natalya Frolova; Adam D Steg; Kun Yuan; Martin R Johnson; William E Grizzle; Renee A Desmond; Andra R Frost
Journal:  Breast Cancer Res Treat       Date:  2009-11-10       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.